Biosimilars Can End Up Drawing A Large Amount of Savings
According to the AHIP report, savings from biosimilars are assumed to exceed $180 billion over the next five years, representing a four-fold increase over...
The Ever-Thriving Pharma Cold Chain Logistics In Europe
In December, the European Commission went on to issue the first approval when it comes to allogenic T-cell therapy in the world, which happened...
Pharma Supply Chain Present Danger As Drug Shortages Rise
Drug shortages endanger national security as well as public health. This is the conclusion of a new report from the United States Senate's Homeland...
World Cell & Gene Therapy Supply Chain To Hit $3.12b By 2031
The global cell and gene therapy (CGT) supply chain and logistics industry is predicted to reach $3.12 billion by 2031, based on a market...
£277m Funding Set To Benefit UK Life Sciences Manufacturing
A £277 million joint government-industry finance package will assist four UK life sciences companies in moving forward with life sciences manufacturing initiatives.
The Life Sciences...
Considerable Rise In Healthcare Deals Expected In 2023
Pharma companies with plenty of cash were on one side of a $200 billion patent cliff. On the other hand, there were a lot...
Significant M&A Agreements Are On The Horizon For 2023
According to EY's 2023 M&A Firepower report, the life sciences sector has record levels of deal-making Firepower, which measures a company's ability to undertake...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...